Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Ceftobiprole – Injectable Anti-MRSA Cephalosporin Antibiotic

Drug (Brand / Generic)

Zeftera or Zevtera / ceftobiprole medocaril

Company / Licensee

Basilea Pharmaceutica AG and Cilag AG International (a J &J company)

Therapy Class

β-lactam (cephalosporin)

Product Description

Antibiotic

Current Indication

Treatment of complicated skin and soft tissue infections, complicated skin and skin structure infections, diabetic foot infections, nosocomial pneumonia

Market Sector

Anti-infectives

Development Status

New drug application rejected in US; approved in Europe, Canada, Ukraine and Switzerland
Expand

Go Top